MA20150243A1 - Préparation thérapeutique et procédé de préparation de ladite préparation thérapeutique - Google Patents

Préparation thérapeutique et procédé de préparation de ladite préparation thérapeutique

Info

Publication number
MA20150243A1
MA20150243A1 MA37392A MA37392A MA20150243A1 MA 20150243 A1 MA20150243 A1 MA 20150243A1 MA 37392 A MA37392 A MA 37392A MA 37392 A MA37392 A MA 37392A MA 20150243 A1 MA20150243 A1 MA 20150243A1
Authority
MA
Morocco
Prior art keywords
therapeutic preparation
preparing
therapeutic
preparation
platelet concentrate
Prior art date
Application number
MA37392A
Other languages
English (en)
Inventor
Andrea Bignotti
Chiara Turelli
Original Assignee
Andrea Bignotti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrea Bignotti filed Critical Andrea Bignotti
Publication of MA20150243A1 publication Critical patent/MA20150243A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une préparation thérapeutique (1) comprenant de l'huile ozonisée et un concentrat plaquettaire (2), mélangée selon un rapport de mélange entre les volumes du concentrat plaquettaire (2) et de l'huile ozonisée (3) substantiellement dans la plage comprise entre 2 et 4.
MA37392A 2012-03-06 2013-03-05 Préparation thérapeutique et procédé de préparation de ladite préparation thérapeutique MA20150243A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000338A ITMI20120338A1 (it) 2012-03-06 2012-03-06 Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
PCT/IB2013/051739 WO2013132428A1 (fr) 2012-03-06 2013-03-05 Préparation thérapeutique et procédé de préparation de ladite préparation thérapeutique

Publications (1)

Publication Number Publication Date
MA20150243A1 true MA20150243A1 (fr) 2015-07-31

Family

ID=45999974

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37392A MA20150243A1 (fr) 2012-03-06 2013-03-05 Préparation thérapeutique et procédé de préparation de ladite préparation thérapeutique

Country Status (18)

Country Link
US (1) US20150071893A1 (fr)
EP (1) EP2822562A1 (fr)
JP (1) JP2015512886A (fr)
CN (1) CN104254335A (fr)
AP (1) AP2014007991A0 (fr)
AU (1) AU2013229128A1 (fr)
CA (1) CA2869364A1 (fr)
EA (1) EA201400985A1 (fr)
IT (1) ITMI20120338A1 (fr)
MA (1) MA20150243A1 (fr)
MD (1) MD20140110A2 (fr)
MX (1) MX2014010686A (fr)
NZ (1) NZ700661A (fr)
PH (1) PH12014502261A1 (fr)
SG (1) SG11201405500YA (fr)
TN (1) TN2014000378A1 (fr)
WO (1) WO2013132428A1 (fr)
ZA (1) ZA201407214B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2644650C2 (ru) 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
CN106615687A (zh) * 2016-11-21 2017-05-10 肖成运 一种新型的复合饲料添加剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336488A (en) * 1991-08-07 1994-08-09 American Cyanamid Company Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines
JPH0971536A (ja) * 1995-07-03 1997-03-18 Nippon Telegr & Teleph Corp <Ntt> 生物細胞含有液凍結乾燥装置
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
US6472210B1 (en) * 1997-11-14 2002-10-29 Bonetec Corporation Polymer scaffold having microporous polymer struts defining interconnected macropores
AU768543B2 (en) * 1998-06-22 2003-12-18 Nuo Therapeutics, Inc. Improved enriched platelet wound healant
ES2216447T3 (es) * 1998-08-17 2004-10-16 Pfizer Products Inc. Composiciones proteicas estabilizadas.
CA2296997A1 (fr) * 2000-01-18 2001-07-18 Vasogen Ireland Limited Traitement de l'insuffisance cardiaque globale
DK1129720T3 (da) * 2000-02-29 2004-09-27 Pfizer Prod Inc Stabiliseret granulocyt-kolonistimulerende faktor
RU2201756C2 (ru) * 2001-03-11 2003-04-10 Вятская государственная сельскохозяйственная академия Способ профилактики и лечения мастита у коров
WO2002100455A2 (fr) * 2001-06-08 2002-12-19 Baylor College Of Medicine Dispositifs medicaux ozones et methodes d'utilisation de l'ozone pour eviter les complications liees aux dispositifs medicaux installes a demeure
RU2238097C2 (ru) * 2002-05-24 2004-10-20 Вятская государственная сельскохозяйственная академия Препарат для лечения и профилактики эндометрита и мастита у коров и способ его приготовления
JP2005112798A (ja) * 2003-10-08 2005-04-28 Atsuya Ogata 動物の炎症又は創傷を治療するための外用治療薬及び治療方法
BRPI0520280A2 (pt) * 2005-05-10 2009-04-28 Us Of America Dept Of Veteran terapia de disfunÇÕes renais e falÊncia méltipla de àrgços com cÉlulas-tronco mesenquimais e meio condicionado por exposiÇço a cÉlulas-tronco mesenquimais
BE1017155A3 (nl) * 2006-06-01 2008-03-04 Sanomedical Bvba Wondverzorgingsproduct.
CN201029956Y (zh) * 2007-05-29 2008-03-05 张全有 动物乳腺炎治疗仪
JP2009235004A (ja) * 2008-03-27 2009-10-15 J Hewitt Kk 細胞組織増加促進方法及び肌問題改善方法並びにこれらに用いるキット

Also Published As

Publication number Publication date
MD20140110A2 (ro) 2015-03-31
AU2013229128A1 (en) 2014-10-23
ZA201407214B (en) 2015-10-28
SG11201405500YA (en) 2014-10-30
WO2013132428A1 (fr) 2013-09-12
TN2014000378A1 (en) 2015-12-21
PH12014502261A1 (en) 2014-12-15
AP2014007991A0 (en) 2014-10-31
MX2014010686A (es) 2015-04-10
JP2015512886A (ja) 2015-04-30
EA201400985A1 (ru) 2015-04-30
CA2869364A1 (fr) 2013-09-12
ITMI20120338A1 (it) 2013-09-07
CN104254335A (zh) 2014-12-31
US20150071893A1 (en) 2015-03-12
EP2822562A1 (fr) 2015-01-14
NZ700661A (en) 2016-08-26

Similar Documents

Publication Publication Date Title
BR112014029752A2 (pt) uso de n-metil-n-acilglucaminas como estabilizadores de frio em soluções de tensoativos
FR2983077B1 (fr) Seringue
MY183637A (en) Compounds and uses thereof for the modulation of hemoglobin
EA201690998A1 (ru) НОВЫЕ СОЕДИНЕНИЯ 3,5-ДИЗАМЕЩЕННОГО-3H-ИМИДАЗО[4,5-b]ПИРИДИНА И 3,5-ДИЗАМЕЩЕННОГО-3H-[1,2,3]ТРИАЗОЛО[4,5-b]ПИРИДИНА КАК МОДУЛЯТОРЫ ПРОТЕИНКИНАЗ
MX370903B (es) Composiciones de ácido percarboxílico estables y sus usos.
BR112014027535A2 (pt) mesa elevatória tipo tesoura e método para construção de uma mesa elevatória tipo tesoura
EA201591748A1 (ru) Модуляторы p2x7
EA201390162A1 (ru) Противораковые соединения, их получение и их терапевтическое применение
BR112014031310A2 (pt) anticorpos anti-pcsk9, formulações, dosagem e métodos de uso
EA201491520A1 (ru) НОВЫЕ СОЕДИНЕНИЯ 3,5-ДИЗАМЕЩЕННОГО-3H-ИМИДАЗО[4,5-b]ПИРИДИНА И 3,5-ДИЗАМЕЩЕННОГО-3H-[1,2,3]ТРИАЗОЛО[4,5-b]ПИРИДИНА КАК МОДУЛЯТОРЫ C-met ПРОТЕИНКИНАЗ
BR112015005270A2 (pt) composições compreendendo peg e ascorbato
UA116908C2 (uk) Сполуки трициклічного бензоксаборолу та їх застосування
EA201992707A1 (ru) Соединения и их применения для модуляции гемоглобина
MA38633B1 (fr) Système à lots multiples pour la préparation d&#39;une solution de bicarbonate de calcium convenant à la reminéralisation d&#39;eau dessalée et d&#39;eau naturellement douce
MA38555A1 (fr) Dérivés de pyrrolo[2,3-d]pyrimidine en tant qu&#39;agonistes du récepteur cb2
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
MA20150243A1 (fr) Préparation thérapeutique et procédé de préparation de ladite préparation thérapeutique
MA35043B1 (fr) Formulation pharmaceutique comprenant de l&#39;inositol
EP4293116A3 (fr) Fibrinogène liquide stable
PH12014501176A1 (en) Anticoagulant reversal agents
RU2012144232A (ru) Грунтовая смесь для дорожного строительства (варианты)
MA42166A1 (fr) Seringue
WO2013021398A3 (fr) Procédé de préparation du chlorure de mivacurium
GB201209015D0 (en) Novel compounds
MA39027B1 (fr) Pyrido[4,3-b]pyrazine-2-carboxamides utilisées en tant qu&#39;agents neurogènes dans le traitement des troubles neurodégénératifs